Copart, Inc. (LON:0ACI)
44.98
0.00 (0.00%)
At close: Sep 29, 2025
Copart Revenue
In the fiscal year ending July 31, 2025, Copart had annual revenue of $4.65B USD with 9.68% growth. Copart had revenue of $1.13B in the quarter ending July 31, 2025, with 5.25% growth.
Revenue
$4.65B
Revenue Growth
+9.68%
P/S Ratio
9.22
Revenue / Employee
$336.74K
Employees
13,800
Market Cap
32.39B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2025 | 4.65B | 410.13M | 9.68% |
Jul 31, 2024 | 4.24B | 367.31M | 9.49% |
Jul 31, 2023 | 3.87B | 368.60M | 10.53% |
Jul 31, 2022 | 3.50B | 808.41M | 30.02% |
Jul 31, 2021 | 2.69B | 486.93M | 22.08% |
Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 198.54B |
Unilever | 51.24B |
Rolls-Royce Holdings | 19.54B |
British American Tobacco p.l.c. | 25.60B |
Rio Tinto Group | 39.22B |
GSK plc | 31.63B |